Inaladuo Accuhaler 50 micrograms/250 micrograms/inhalation, powder for inhalation

Spain
Brand name Inaladuo Accuhaler 50 micrograms/250 micrograms/inhalation, powder for inhalation
Form powder for inhalation
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 62868
Inaladuo Accuhaler 50 micrograms/250 micrograms/inhalation, powder for inhalation powder for inhalation

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Inaladuo Accuhaler 50 micrograms/250 micrograms/inhalation, inhalation powder

salmeterol/fluticasone propionate

Read the entire leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What Inaladuo is and what it is used for
  2. What you need to know before using Inaladuo
  3. How to use Inaladuo
  4. Possible side effects
  5. How to store Inaladuo
  6. Contents of the pack and other information

1. What Inaladuo is and what it is used for

Inaladuo contains two active substances, salmeterol and fluticasone propionate:

  • Salmeterol is a long-acting bronchodilator. Bronchodilators help keep the airways in the lungs open, making it easier to breathe in and out. The effects last for at least 12 hours.
  • Fluticasone propionate is a corticosteroid that reduces inflammation and irritation in the lungs.

Your doctor has prescribed this medicine to help prevent breathing problems such as:

  • Asthma.
  • Chronic Obstructive Pulmonary Disease (COPD). Inaladuo Accuhaler, at a dose of 50/500 micrograms, reduces the number of exacerbations of COPD symptoms.

You should use Inaladuo every day as directed by your doctor. This will ensure that the medication works effectively in controlling your asthma or COPD.

Inaladuo helps prevent breathlessness and wheezing. However, Inaladuo should not be used to relieve a sudden attack of breathlessness or wheezing. In such cases, you must use your fast-acting "rescue" medication, such as salbutamol. You should always carry your fast-acting rescue medication with you.

2. What you need to know before using Inaladuo

Do not use Inaladuo

  • if you are allergic to salmeterol, fluticasone propionate, or any of the other ingredients, lactose monohydrate.

Warnings and precautions

Talk to your doctor before starting treatment if you have:

  • Heart problems, including rapid or irregular heartbeat.
  • Overactive thyroid.
  • High blood pressure.
  • Diabetes mellitus (Inaladuo may increase blood sugar levels).
  • Low potassium levels in the blood.
  • Current or past tuberculosis (TB) or other lung infections.

Contact your doctor if you experience blurred vision or other visual disturbances.

Using Inaladuo with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including medicines for asthma or those obtained without a prescription. This is because, in some cases, Inaladuo should not be taken together with certain other medicines.

Inform your doctor if you are taking any of the following medicines before starting Inaladuo:

  • β-blockers (such as atenolol, propranolol, and sotalol). β-blockers are mainly used to treat high blood pressure or other heart conditions.
  • Medicines to treat infections (such as ketoconazole, itraconazol, and erythromycin), including some medicines for HIV (such as ritonavir, cobicistat). Some of these medicines may increase the amount of fluticasone propionate or salmeterol in your body. This may increase your risk of adverse effects with Inaladuo, including irregular heartbeats, or may worsen side effects, so your doctor will monitor you closely if you are taking these medicines.
  • Corticosteroids (oral or injectable). If you have recently taken these medicines, there may be an increased risk that this medicine could affect your adrenal gland.
  • Diuretics, also known as "water pills", used to treat high blood pressure.
  • Other bronchodilators (such as salbutamol).
  • Medicines containing xanthines. These are often used to treat asthma.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Inaladuo is unlikely to affect your ability to drive or use machinery.

Inaladuo Accuhaler contains lactose

Inaladuo Accuhaler contains up to 12.5 milligrams of lactose monohydrate per dose. The amount of lactose in this medicine is not usually a problem for people with lactose intolerance. However, it may cause allergic reactions in patients allergic to cow's milk protein. If your doctor has told you that you have an intolerance to certain sugars, consult with them before using this medicine.

3. How to use Inaladuo

Follow exactly the instructions for administering this medicine as given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

  • Use Inaladuo every day until your doctor tells you to stop. Do not take more than the recommended dose. If in doubt, consult your doctor or pharmacist.
  • Do not stop taking Inaladuo or reduce your dose without first talking to your doctor.
  • Inaladuo must be inhaled through the mouth into the lungs.
  • You may not taste or feel the powder on your tongue, even if you have used the Accuhaler correctly.

For asthma

Adults and adolescents aged 12 years and older

  • Inaladuo 50/100 Accuhaler: One inhalation twice daily
  • Inaladuo 50/250 Accuhaler: One inhalation twice daily
  • Inaladuo 50/500 Accuhaler: One inhalation twice daily

Children aged 4 to 12 years

  • Inaladuo 50/100 Accuhaler: One inhalation twice daily
  • Inaladuo is not recommended for use in children under 4 years of age.

For adults with Chronic Obstructive Pulmonary Disease (COPD)

  • Inaladuo 50/500 Accuhaler: One inhalation twice daily

Your symptoms may become well controlled with Inaladuo taken twice daily. If so, your doctor may decide to reduce your dose to once daily. The dose may be changed to:

  • once at night if you have nocturnal symptoms,
  • once in the morning if you have diurnal symptoms.

It is very important that you follow your doctor's instructions on how many inhalations and how often you should take your medication.

If you are using Inaladuo to treat asthma, your doctor will want to monitor your symptoms regularly.

If your asthma worsens or you have increasing difficulty breathing, see your doctor immediately. You may notice more wheezing or breathlessness more often, or find you need to use your fast-acting rescue medication more frequently. If any of these occur, you must continue using Inaladuo, but do not increase the number of inhalations. Your respiratory condition may worsen and you may become seriously ill. See your doctor, as you may need additional treatment.

Instructions for use

  • Your doctor, nurse, or pharmacist should show you how to use your inhaler. They should periodically check that you are using it correctly. Incorrect or improper use of the Inaladuo Accuhaler may result in your asthma or COPD not being properly controlled.
  • This Accuhaler contains blisters containing Inaladuo powder.
  • There is a dose counter on the top of the Accuhaler indicating how many doses remain. It counts down to 0. Numbers from 5 to 0 appear in red to warn you that only a few doses remain. Once the counter reaches 0, your inhaler is empty.

Using your inhaler

  1. To open the Accuhaler, hold the outer case in one hand and place the thumb of the other hand in the designated thumb grip. Push the thumb away from you as far as it will go. You will hear a "click". This opens a small hole in the mouthpiece.
Two hands holding and rotating a circular medical device to the right, indicated by a curved white arrow
  1. Hold the device with the mouthpiece facing you. You may hold it in either your right or left hand. Slide the lever away from you. You will hear a "click". This delivers a dose of medication into the mouthpiece.
Two hands holding a cylindrical medical device with a white arrow indicating a rotational movement to the

Each time the lever is slid back, a blister is opened and the powder is prepared for inhalation. Do not play with the lever, as this opens the blisters and wastes medication.

  1. Keep the Accuhaler away from your mouth. Breathe out as fully as reasonably possible. Do not breathe into the Accuhaler.

  2. Place the mouthpiece in your mouth; inhale steadily and deeply through the Accuhaler, not through your nose.

Remove the Accuhaler from your mouth.

Hold your breath for about 10 seconds, or as long as possible.

Breathe out slowly.

Black and white drawing of a person's profile inserting a tablet or solid medication into the mouth with the hand
  1. After use, rinse your mouth with water, spit it out, and/or brush your teeth. This may help prevent mouth ulcers and hoarseness.

  2. To close the Accuhaler, slide the lever towards you with your thumb as far as it will go. You will hear a "click".

The lever will automatically return to its original position.

Two hands holding a circular container and rotating it to the left following the direction indicated by a curved white arrow

The Accuhaler is now ready for reuse.

As with all inhalers, caregivers must ensure that children using Inaladuo Accuhaler use the correct inhalation technique described above.

Cleaning your inhaler

To clean, wipe the mouthpiece of the Accuhaler with a dry tissue.

If you use more Inaladuo than you should

It is very important to use the inhaler as directed. If you accidentally take a higher dose than recommended, consult your doctor or pharmacist. You may notice your heart beating faster than normal and feel tremors. You may also experience dizziness, headache, muscle weakness, and joint pain.

If you have used large doses over long periods of time, you should seek advice from your doctor or pharmacist. This is because high concentrations of Inaladuo may reduce the amount of steroid hormones produced by the adrenal gland.

In case of overdose, contact your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, stating the medication and the amount taken.

If you forget to use Inaladuo

Do not take a double dose to make up for missed doses. Take the next dose at your usual time.

If you stop using Inaladuo

It is very important that you use Inaladuo every day as instructed. Continue taking it until your doctor tells you to stop. Do not stop treatment with Inaladuo abruptly. This could cause your breathing to worsen.

Additionally, if you suddenly stop taking Inaladuo or reduce your dose, you could (very rarely) develop problems with your adrenal gland (adrenal insufficiency), which may sometimes cause adverse effects.

These adverse effects may include any of the following:

  • Stomach pain.
  • Tiredness and loss of appetite, feeling unwell.
  • Nausea and diarrhea.
  • Weight loss.
  • Headache or drowsiness.
  • Low blood sugar levels.
  • Low blood pressure and seizures (fits).

When your body is under stress due to fever, trauma (e.g., traffic accident), infection, or surgery, adrenal insufficiency may worsen, and you may experience any of the adverse effects listed above.

If you experience any adverse effects, consult your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe an additional dose of oral corticosteroids during that time (such as prednisolone).

If you have any further questions about the use of this medicine, ask your doctor, nurse, or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them. To reduce the occurrence of adverse effects, your doctor will prescribe the lowest dose of Inaladuo that controls your asthma or Chronic Obstructive Pulmonary Disease (COPD).

Allergic reactions: you may notice that your breathing suddenly worsens immediately after using Inaladuo. You may experience wheezing, coughing, or shortness of breath. You may also notice itching, rash (urticaria), and swelling (usually of the face, lips, tongue, or throat).

You may also suddenly feel that your heart is beating very fast, feel faint or dizzy (which may lead to collapse or loss of consciousness). If you experience any of these effects, or if they occur suddenly after using Inaladuo, stop taking Inaladuo and contact your doctor immediately. Allergic reactions to Inaladuo are uncommon (affecting fewer than 1 in 100 people).

Pneumonia (lung infection) in patients with COPD (a common adverse effect)

Inform your doctor if you experience any of the following symptoms while inhaling Inaladuo, as they could be signs of a lung infection:

  • Fever or chills
  • Increased mucus production, change in the color of mucus
  • Worsening cough or increased difficulty breathing

The following are other adverse effects:

Very common (may affect more than 1 in 10 people)

  • Headache, which usually improves with continued treatment.
  • Increased incidence of colds has been reported in patients with Chronic Obstructive Pulmonary Disease (COPD).

Common (may affect up to 1 in 10 people)

  • Oral candidiasis (itching, appearance of creamy yellow lesions) in the mouth and throat. Also, tongue pain, hoarseness, and throat irritation. Rinsing your mouth with water and spitting it out and/or brushing your teeth immediately after each dose of medication may help. For treatment of candidiasis, your doctor may prescribe antifungal medication (to treat fungal infections).
  • Joint pain, joint swelling, and muscle pain.
  • Muscle cramps.

The following adverse effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):

  • Bruising and fractures.
  • Sinus inflammation (feeling of pressure or congestion in the nose, cheeks, and behind the eyes, sometimes with throbbing pain).
  • Reduction in blood potassium levels (you may feel irregular heartbeats, muscle weakness, cramps).

Uncommon (may affect up to 1 in 100 people)

  • Increased blood sugar (glucose) levels (hyperglycaemia). If you have diabetes, your blood sugar levels will need to be monitored more frequently, and your usual diabetes treatment may need to be adjusted if necessary.
  • Cataracts (clouding of the eye's lens).
  • Very fast heart rate (tachycardia).
  • Tremors and a fast or irregular heartbeat (palpitations). These adverse effects are usually harmless and decrease with continued treatment.
  • Chest pain.
  • Feeling of anxiety (occurs mainly in children).
  • Sleep disorders.
  • Skin rash.
  • Allergic skin reaction.

Rare (may affect up to 1 in 1,000 people)

  • Worsening of breathing difficulty (or wheezing) immediately after using Inaladuo. If this occurs, stop using Inaladuo. Use your fast-acting "rescue" inhaler to improve your breathing and contact your doctor immediately.

  • Inaladuo may increase the normal production of steroid hormones, particularly if you have been taking high doses for long periods of time. Effects include:

  • Growth retardation in children and adolescents.

  • Decreased bone mineral density.

  • Glaucoma.

  • Weight gain.

  • Rounded face (moon face) (Cushing's syndrome).

Your doctor will regularly monitor for any of these adverse effects and ensure you are taking the lowest effective dose of Inaladuo to control your asthma.

  • Changes in behavior, such as hyperactivity and irritability (these effects occur mainly in children).
  • Irregular heartbeats or extra heartbeats (arrhythmias). Consult your doctor, but do not stop taking Inaladuo unless your doctor tells you to.
  • Fungal infection of the esophagus (throat), which may cause difficulty swallowing.

Frequency not known, but may also occur:

  • Depression or aggression. These effects are more likely to occur in children.
  • Blurred vision

Reporting of adverse effects

If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Inaladuo

Keep this medicine out of the sight and reach of children.

Do not use Inaladuo after the expiry date stated on the label and the carton after EXP. The expiry date refers to the last day of the month indicated.

Do not store above 30°C.

Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE point located at your pharmacy. If you are unsure, ask your pharmacist how to dispose of unused medicines and their packaging. This will help protect the environment.

6. Contents of the pack and other information

Composition of Inaladuo

  • Each pre-dispensed dose contains 50 micrograms of salmeterol (as salmeterol xinafoate) and 250 micrograms of fluticasone propionate.
  • The other component is lactose monohydrate (contains milk proteins).

What the medicine looks like and contents of the pack

Inaladuo Accuhaler contains a strip of blisters. The blisters protect the inhaled powder from atmospheric effects.

Each dose is pre-dispensed.

The devices are supplied in packs of 1 Accuhaler x 60 inhalations.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Manufacturer:

Glaxo Wellcome Production

Zone Industrielle nº 2, 23 Rue Lavoisier, La Madeleine, 27000 Evreux, France.

Tel: +33 2 3223 5500

Fax: +33 2 3223 5558

or

Aspen Bad Oldesloe GmbH

Industriestrasse 32-36, 23843 Bad Oldesloe, Germany.

This patient information leaflet was last reviewed in July 2020.

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/